Skip to main content
Erschienen in: Journal of General Internal Medicine 3/2007

01.03.2007 | Original Article

Physicians’ Perspectives on Prescribing Benzodiazepines for Older Adults: A Qualitative Study

verfasst von: Joan M. Cook, PhD, Randall Marshall, MD, Christina Masci, MS, James C. Coyne, PhD

Erschienen in: Journal of General Internal Medicine | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Background

There is a continued high prevalence of benzodiazepine use by older community-residing adults and of their continued prescription by practitioners, despite well known adverse effects and the availability of safer, effective alternatives.

Objectives

To understand factors influencing chronic use of benzodiazepines in older adults.

Design

Qualitative study, semistructured interviews with physicians.

Participants

Thirty-three practicing primary care physicians around Philadelphia.

Approach

Qualitative interviews were audiotaped, transcribed, and entered into a qualitative software program. A multidisciplinary team coded transcripts and developed themes.

Results

Physicians generally endorsed benzodiazepines as effective treatment for anxiety, citing quick action and strong patient satisfaction. The use of benzodiazepines in older adults was not seen to be problematic because they did not show drug-seeking or escalating dose behavior suggesting addiction. Physicians minimized other risks of benzodiazepines and did not view monitoring or restricting renewal of prescriptions as an important clinical focus relative to higher-priority medical issues. Many physicians expressed skepticism about risks of continued use and considerable pessimism in the successful taper/discontinuation in older patients with long-term use and prior failed attempts. Physicians also anticipated patient resistance to any such efforts, including switching physicians.

Conclusions

Primary care physicians are averse to addressing the public health problem of benzodiazepine overuse in the elderly. Their attitudes generally conflict with practice guidelines and they complain of a lack of training in constructive strategies to address this problem. A 2-pronged effort should focus on increasing skill level and preventing new cases of benzodiazepine dependency through improved patient education and vigilant monitoring of prescription renewal.
Literatur
1.
Zurück zum Zitat Hemmelgarn B, Suissa S, Huang A, Boivin JF, Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA. 1997;278:27–31.PubMedCrossRef Hemmelgarn B, Suissa S, Huang A, Boivin JF, Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA. 1997;278:27–31.PubMedCrossRef
2.
Zurück zum Zitat Pomara N, Tun H, DaSilva D, Hernando R, Deptula D, Greenblatt DJ. The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation. Psychopharmacol Bull. 1998;34:139–53.PubMed Pomara N, Tun H, DaSilva D, Hernando R, Deptula D, Greenblatt DJ. The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation. Psychopharmacol Bull. 1998;34:139–53.PubMed
3.
Zurück zum Zitat Ried LD, Johnson RE, Gettman DA. Benzodiazepine exposure and functional status in older people. J Am Geriatr Soc. 1998;46:71–6.PubMed Ried LD, Johnson RE, Gettman DA. Benzodiazepine exposure and functional status in older people. J Am Geriatr Soc. 1998;46:71–6.PubMed
4.
Zurück zum Zitat Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry. 2001;158:892–8.PubMed Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry. 2001;158:892–8.PubMed
5.
Zurück zum Zitat Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331:1169–73.PubMedCrossRef Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331:1169–73.PubMedCrossRef
6.
Zurück zum Zitat Stewart S. The effects of benzodiazepines on cognition. J Clin Psychiatry. 2005;66 (suppl 2):9–13.PubMed Stewart S. The effects of benzodiazepines on cognition. J Clin Psychiatry. 2005;66 (suppl 2):9–13.PubMed
7.
Zurück zum Zitat American Psychiatric Association. Task Force on Benzodiazepine Dependency. Benzodiazepine dependence, toxicity, and abuse. Washington, DC: Author; 1990. American Psychiatric Association. Task Force on Benzodiazepine Dependency. Benzodiazepine dependence, toxicity, and abuse. Washington, DC: Author; 1990.
8.
Zurück zum Zitat NIH Consensus Development Conference. Drugs and insomnia: the use of medications to promote sleep. JAMA. 1984;251:2410–14.CrossRef NIH Consensus Development Conference. Drugs and insomnia: the use of medications to promote sleep. JAMA. 1984;251:2410–14.CrossRef
9.
Zurück zum Zitat Llorente MD, David S, Golden AG, Silverman MA. Defining patterns of benzodiazepine use in older adults. J Geriatr Psychiatry Neurol. 2000;13:150–60.PubMed Llorente MD, David S, Golden AG, Silverman MA. Defining patterns of benzodiazepine use in older adults. J Geriatr Psychiatry Neurol. 2000;13:150–60.PubMed
10.
Zurück zum Zitat Gleason PP, Schulz R, Smith NL, et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med. 1998;13:243–50.PubMedCrossRef Gleason PP, Schulz R, Smith NL, et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med. 1998;13:243–50.PubMedCrossRef
11.
Zurück zum Zitat Fialova D, Topinkova E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293:1348–58.PubMedCrossRef Fialova D, Topinkova E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293:1348–58.PubMedCrossRef
12.
Zurück zum Zitat Hanlon JT, Schmader KE, Boult C, et al. Use of inappropriate prescription drugs by older people. J Am Geriatr Soc. 2002;50:26–34.PubMedCrossRef Hanlon JT, Schmader KE, Boult C, et al. Use of inappropriate prescription drugs by older people. J Am Geriatr Soc. 2002;50:26–34.PubMedCrossRef
13.
Zurück zum Zitat Miles M, Huberman A. (1994). Qualitative Data Analysis. Sage, London. Miles M, Huberman A. (1994). Qualitative Data Analysis. Sage, London.
14.
Zurück zum Zitat Nutting PA, Rost K, Dickinson M, et al. Barriers to initiating depression treatment in primary care practice. J Gen Intern Med. 2002;17:103–11.PubMedCrossRef Nutting PA, Rost K, Dickinson M, et al. Barriers to initiating depression treatment in primary care practice. J Gen Intern Med. 2002;17:103–11.PubMedCrossRef
15.
Zurück zum Zitat Forsetlund L, Talseth KO, Bradley P, Nordheim L, Bjorndal A. Many a slip between cup and lip: process evaluation of a program to promote and support evidence-based public health practice. Eval Rev. 2003;27:179–209.PubMedCrossRef Forsetlund L, Talseth KO, Bradley P, Nordheim L, Bjorndal A. Many a slip between cup and lip: process evaluation of a program to promote and support evidence-based public health practice. Eval Rev. 2003;27:179–209.PubMedCrossRef
16.
Zurück zum Zitat Heather N, Bowie A, Ashton H, et al. Randomised controlled trial of two brief interventions against long-term benzodiazepine use: outcome of intervention. Addict Res Theory. 2004;12:141–54.CrossRef Heather N, Bowie A, Ashton H, et al. Randomised controlled trial of two brief interventions against long-term benzodiazepine use: outcome of intervention. Addict Res Theory. 2004;12:141–54.CrossRef
17.
Zurück zum Zitat Cormack MA, Sweeney KG, Hughes-Jones H, et al. Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice. Br J Gen Pract. 1994;44:5–8.PubMed Cormack MA, Sweeney KG, Hughes-Jones H, et al. Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice. Br J Gen Pract. 1994;44:5–8.PubMed
18.
Zurück zum Zitat Bashir K, King M, Ashworth M. Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. Br J Gen Pract. 1994;44:408–12.PubMed Bashir K, King M, Ashworth M. Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. Br J Gen Pract. 1994;44:408–12.PubMed
19.
Zurück zum Zitat National Health Service Management Executive. The health of the nation: first steps for the NHS. Londong: NHSME, 1992. National Health Service Management Executive. The health of the nation: first steps for the NHS. Londong: NHSME, 1992.
20.
Zurück zum Zitat Pimlott JG, Hux JE, Wilson LM, et al. Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial. CMAJ. 2003;168:835–9.PubMed Pimlott JG, Hux JE, Wilson LM, et al. Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial. CMAJ. 2003;168:835–9.PubMed
21.
Zurück zum Zitat Bambauer KZ, Sabin JE, Soumerai SB. The exclusion of benzodiazepine coverage in Medicare: simple steps for avoiding a public health crisis. Psychiatr Serv. 2005;56:1143–6.PubMedCrossRef Bambauer KZ, Sabin JE, Soumerai SB. The exclusion of benzodiazepine coverage in Medicare: simple steps for avoiding a public health crisis. Psychiatr Serv. 2005;56:1143–6.PubMedCrossRef
22.
Zurück zum Zitat Public Citizen Health Research Group. The risk of tranquility. Health Lett. 1985;1(4):5–6 (September/October). Public Citizen Health Research Group. The risk of tranquility. Health Lett. 1985;1(4):5–6 (September/October).
23.
Zurück zum Zitat Wolfe SM, Levin JD, Sobel P. Public Citizen Health Research Group. Testimony before the drug abuse advisory committee meeting. 1981, May 14. Wolfe SM, Levin JD, Sobel P. Public Citizen Health Research Group. Testimony before the drug abuse advisory committee meeting. 1981, May 14.
24.
Zurück zum Zitat Medicare Rights Center. Critical Coverage: Benzodiazepines under Medicare Part D. Washington, DC; Author:2005. Medicare Rights Center. Critical Coverage: Benzodiazepines under Medicare Part D. Washington, DC; Author:2005.
Metadaten
Titel
Physicians’ Perspectives on Prescribing Benzodiazepines for Older Adults: A Qualitative Study
verfasst von
Joan M. Cook, PhD
Randall Marshall, MD
Christina Masci, MS
James C. Coyne, PhD
Publikationsdatum
01.03.2007
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 3/2007
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-006-0021-3

Weitere Artikel der Ausgabe 3/2007

Journal of General Internal Medicine 3/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.